Oct 7, 2016, 10:52 AM by Michael Croft

Omics! Omics! Blog | Keith Robison comments on what he calls a misguided call for a moonshot in human disease from Bill Gates. Gates recently laid out four goals for disease prevention he believes can be attained in the next decade.

Oct 6, 2016, 16:20 PM by Michael Croft

WESTMINSTER, CA, UNITED STATES - Oct 7, 2016 - Chronic pain is a debilitating condition that is difficult to treat. Many people that suffer from chronic pain are not able to complete daily tasks to maintain their lifestyle simply because the pain is too great

Oct 6, 2016, 12:10 PM by Michael Croft

EAST LYME, CT, USA - Oct 6, 2016 - American Laboratory Trading Inc. (ALT), the largest provider of premium refurbished lab equipment in North America, has been selected by Agilent Technologies to be a part of its Channel Partnership Program

Oct 6, 2016, 11:04 AM by Michael Croft

Forbes | Before Brands, a business that wants to prevent food allergies before they even start, launched this morning with $13.1 million in funding from backers including Gurnet Point, run by biotech billionaire Ernesto Bertarelli.

Oct 6, 2016, 10:16 AM by Michael Croft

Science | AAAS | Unusual maneuver in CRISPR patent battle could divide spoils, but French company Cellectis also lays claim.

Oct 6, 2016, 07:34 AM by Michael Croft

ALBANY, NY, UNITED STATES - Oct 6, 2016 - The concept of health insurance, in general, is objectively simple whereinan individual or organization purchase services or plans to avoid their risk in event of un-avoidable health conditions

Oct 5, 2016, 13:57 PM by Michael Croft

CAMBRIDGE, MA - Oct 5, 2016 -  IOMICS today announced the release of its first vertical product, FUSION STS, a new class of chemical analytics that will allow scientists and chemical engineers to rapidly build and deploy in silico HTS systems that can be used stand-alone or to augment in vitro screening initiatives

Oct 5, 2016, 09:56 AM by Michael Croft

KANSAS CITY, KS, UNITED STATES - Oct 5, 2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems. These products contain high concentrations of lysosomal degradative enzymes and constitute advantageous test systems for analysis of catabolism and/or activation for targeted biopharmaceuticals that enter cells through the endosomal-lysosomal pathway

Oct 5, 2016, 09:15 AM by Michael Croft

POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.

Oct 5, 2016, 08:38 AM by Michael Croft

BETHESDA, MD - Oct 5, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Jeffrey I

Oct 5, 2016, 07:00 AM by Michael Croft

Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.

Oct 5, 2016, 04:22 AM by Michael Croft

FONTAINE, FRANCE - Oct 3, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has launched a showcase line for serialisation, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulations

Oct 4, 2016, 15:34 PM by Michael Croft

ZDNet | Microsoft's CEO on how its cloud computing service is evolving.

Oct 4, 2016, 14:17 PM by Michael Croft

CRYSTAL LAKE, IL, UNITED STATES - Oct 4, 2016 - Treatments utilizing regenerative medicine cause our body’s natural healing processes to work both more effectively and rapidly

Oct 4, 2016, 12:43 PM by Michael Croft

CHAPEL HILL, NC, UNITED STATES - Oct 3, 2016 - TARGET PharmaSolutions, Inc. is pleased to announce the launch of TARGET-PBC (Primary Biliary Cholangitis)

Oct 4, 2016, 10:49 AM by Michael Croft

Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.

Oct 4, 2016, 10:14 AM by Michael Croft

BASEL, N/A, SWITZERLAND - Oct 4, 2016 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® version 14

Oct 4, 2016, 05:47 AM by Michael Croft

DUDLEY, UK - Oct 3, 2016 - UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley site

Oct 3, 2016, 14:30 PM by Michael Croft

Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.

Sep 30, 2016, 08:34 AM by Michael Croft

ALBANY, NY, UNITED STATES - Sep 30, 2016 - H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine flu